Advances of Mechanisms-Related Metabolomics in Parkinson’s Disease

Advances of Mechanisms-Related Metabolomics in Parkinson’s Disease
Front Neurosci. 2021 Feb 3;15:614251. doi: 10.3389/fnins.2021.614251. eCollection 2021.ABSTRACTParkinson's disease (PD) is a multifactorial disorder characterized by progressively debilitating dopaminergic neurodegeneration in the substantia nigra and the striatum, along with various metabolic dysfunctions and molecular abnormalities. Metabolomics is an emerging study and has been demonstrated to play important roles in describing complex human diseases by integrating endogenous and exogenous sources ... read more
Source: PubMedPublished on 2021-02-22By Yanyan Zhang